Andrea Matthews
Corporate Officer/Principal chez ASTRIA THERAPEUTICS, INC.
Fortune : - $ au 31/05/2024
Provenance du réseau au premier degré de Andrea Matthews
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 31 | |
Selventa, Inc.
Selventa, Inc. Miscellaneous Commercial ServicesCommercial Services Selventa, Inc. develops new approaches for the understanding and treatment of diseases. It focuses on elucidating the complexity of biology for the development of safe and effective therapeutics and molecular diagnostics. The company was founded in 2002 by Keith O. Elliston and Noubar B. Afeyan and is headquartered in Cambridge, MA.
16
| Extinct | Miscellaneous Commercial Services | 16 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Andrea Matthews via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree Masters Business Admin Doctorate Degree Undergraduate Degree | |
Massachusetts Institute of Technology | College/University | Doctorate Degree Director/Board Member Graduate Degree Corporate Officer/Principal Doctorate Degree | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Sales & Marketing Chief Tech/Sci/R&D Officer Sales & Marketing Chief Tech/Sci/R&D Officer | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer | |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | President Corporate Officer/Principal Corporate Officer/Principal | |
ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Chief Executive Officer Private Equity Investor Private Equity Investor | |
Boston College | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
BIOGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
University of Pennsylvania | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
Boston College Law School | College/University | Graduate Degree Graduate Degree | |
Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal | |
TETRALOGIC PHARMACEUTICALS CORPORATION | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
McGill University | College/University | Graduate Degree Undergraduate Degree | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Masters Business Admin Undergraduate Degree | |
PROGENICS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
Syntimmune, Inc.
Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member Chief Executive Officer | |
Tufts University School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Hospital/Nursing Management | Director/Board Member Corporate Officer/Principal | |
Midori USA, Inc.
Midori USA, Inc. Miscellaneous Commercial ServicesCommercial Services Midori USA, Inc. develops cellulosic technology for conversion of biomass to fuels. It offers biomass barrier technology that melts and digests biomass into sugars with a solid, recyclable catalyst. The company was founded by J. M. Geremia and Brian Baynes in 2008 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
SANA BIOTECHNOLOGY, INC. | Biotechnology | Founder Chief Tech/Sci/R&D Officer | |
CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Chairman General Counsel | |
ATV Capital Management Inc.
ATV Capital Management Inc. Investment ManagersFinance ATV Capital Management Inc. (ATV Capital Management) is a venture capital firm founded in 1979. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor General Counsel | |
Quellis Biosciences LLC
Quellis Biosciences LLC Pharmaceuticals: MajorHealth Technology Quellis Biosciences, Inc. operates as a biotechnology company. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
CALITHERA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
LSV CAPITAL MANAGEMENT LLC
LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management LLC (Lightstone Ventures) is a venture capital firm founded in 2012. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor General Counsel | |
ARIAD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Williams College | College/University | Undergraduate Degree Undergraduate Degree | |
Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Chief Executive Officer Private Equity Investor | |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Director/Board Member | |
AlloCure, Inc.
AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Biotechnology | Director/Board Member | |
AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
HemoShear Therapeutics, Inc.
HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | Medical/Nursing Services | Corporate Officer/Principal |
Statistiques
Internationale
Etats-Unis | 49 |
Canada | 2 |
Irlande | 2 |
Sectorielle
Health Technology | 28 |
Consumer Services | 13 |
Finance | 7 |
Health Services | 3 |
Commercial Services | 3 |
Opérationnelle
Director/Board Member | 243 |
Corporate Officer/Principal | 123 |
Founder | 64 |
Independent Dir/Board Member | 63 |
Chairman | 49 |
Relations les plus connectées
Insiders | |
---|---|
Noubar Afeyan | 76 |
Michael Ross | 44 |
Jean George | 33 |
Michael Grey | 32 |
Arnold Levine | 30 |
Gregg Lapointe | 25 |
Burt Adelman | 23 |
Stephen D. Chubb | 20 |
Ken Bate | 19 |
Jim Matheson | 19 |
Sunil Agarwal | 17 |
John Tagliamonte | 12 |
Joanne Beck | 12 |
Frederick Callori | 11 |
Jonathan Violin | 11 |
- Bourse
- Insiders
- Andrea Matthews
- Connexions Sociétés